GlassScriptPhysician profile
Richard J Miller
NPI 1194723809
$2,658.30
in general payments reported to CMS, 2019-2025
28 companies · $28.07 in 2025
The $28.07 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $51.76 · 2021: $148 · 2022: $1,167 · 2023: $609 · 2024: $369 · 2025: $28.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Koya Medical, INC. | $647.56 | 2022 | |
| Stryker Corporation | $499.95 | 2022-2024 | Gravity, Ortholoc 3di, Smart Toe |
| Horizon Therapeutics Plc | $221.37 | 2019-2023 | Krystexxa |
| Sebela Pharmaceuticals INC. | $205.01 | 2019-2023 | Naftin |
| Convatec INC. | $125.62 | 2023-2024 | |
| Smith+Nephew, INC. | $121.56 | 2022-2024 | Grafix Pl, Stravix, Grafix |
| Abbvie INC. | $98.72 | 2023-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $80.97 | 2019-2024 | Jublia |
| Bioventus LLC | $80.66 | 2022-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $55.03 | 2021-2023 | Puraply |
| Journey Medical Corporation | $52.42 | 2021 | |
| Nevro Corp. | $49.29 | 2024 | Senza |
| Abbott Laboratories | $44.06 | 2022-2023 | Proclaim |
| Peerless Surgical INC. | $38.89 | 2021 | |
| Orthofix Medical, INC. | $34.50 | 2023 | Physio-Stim |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $33.30 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Next Science LLC | $28.69 | 2023 | Blastx, Surgx, Xperience |
| Globus Medical, INC. | $28.07 | 2025 | Omnia |
| Alfasigma USA, INC. | $26.96 | 2022 | |
| Fidia Pharma USA INC. | $26.61 | 2019 | |
| Averitas Pharma INC. | $26.31 | 2023 | Qutenza |
| Paratek Pharmaceuticals, INC. | $23.59 | 2022 | |
| Grt US Holding, INC. | $23.39 | 2022 | |
| Depuy Synthes Sales INC. | $19.94 | 2024 | |
| Treace Medical Concepts, INC. | $18.81 | 2022 | |
| Zimmer Biomet Holdings, INC. | $17.46 | 2019 | |
| Amgen INC. | $16.16 | 2024 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $13.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.